Clinical Trials Logo

Post-Operative Delirium clinical trials

View clinical trials related to Post-Operative Delirium.

Filter by:

NCT ID: NCT00791648 Completed - Acute Kidney Injury Clinical Trials

Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery

Start date: July 2009
Phase: N/A
Study type: Interventional

Aim1a: Statin naive patient's scheduled for cardiac surgery will be randomized to 80mg atorvastatin or placebo on the day prior to surgery and then 40mg daily thereafter until hospital discharge to test the hypothesis that short-term atorvastatin use decreases: 1. acute kidney injury following cardiac surgery. 2. postoperative delirium following cardiac surgery. Aim1b: Patients using statins preoperatively will be randomized to atorvastatin 80mg or placebo on day of surgery and 40mg or placebo on postop day 1 with resumption of preoperative statin therapy on postop day 2 to test the hypothesis that short-term atorvastatin use decreases: 1. acute kidney injury following cardiac surgery. 2. postoperative delirium following cardiac surgery. Endpoints include glomerular filtration, urine and plasma markers of renal dysfunction, markers of oxidative stress, mitochondrial function, systemic inflammatory markers, delirium, dialysis, stroke, myocardial infarction, time to extubation, ICU length of stay, and death.

NCT ID: NCT00250237 Completed - Hip Fracture Clinical Trials

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

Start date: November 2005
Phase: Phase 3
Study type: Interventional

In this study the investigators want to determine if treatment with haloperidol direct post-operatively after acute hip surgery in high risk patients protects against developing a post-operative delirium.